World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Welcome to the World Journal of Clinical Oncology

Safety level for indication of immunotherapeutic drugs in the treatment of lung cancer.

Indoleamine 2,3-dioxygenase inhibition as potential immunotherapeutic strategy for breast cancer.

Pulse structure.

Column type distribution of manuscripts published in World Journal of Clinical Oncology in 2020.

Distribution of authors’ countries for the manuscripts published in World Journal of Clinical Oncology in 2020.

‹ ›

Phytochemically rich dietary components and the risk of colorectal cancer: A systematic review and meta-analysis of observational studies

Featured Articles More >>

Phytochemically rich dietary components and the risk of colo... 2021-06-18
Imaging diagnosis of bronchogenic carcinoma (the forgotten d... 2021-06-18
Review of 10 years of research on breast cancer patients: Fo... 2021-06-18
Breast cancer: Muscarinic receptors as new targets for tumor... 2021-06-18
Health Council of the Netherlands and evaluation of the fift... 2021-06-18

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 737440

Number of visits today: 28

Number of downloads: 288705

MEMBERSHIP

BPG JOURNALS

GUIDELINES FOR AUTHORS

World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>

2021 Published Issues

6 5 4 3 2 1

Editors-in-Chief

Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Professor, Surgical Oncologist, (E-mail: hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway (UNN), Tromso 9038, Norway
Stephen Safe, PhD, Professor, (E-mail: ssafe@cvm.tamu.edu) Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77845, United States

Indexing/Abstracting

The WJCO is now abstracted and indexed in PubMed, PubMed Central, Emerging Sources Citation Index (Web of Science), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.

Journal Metrics

IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241; CiteScore (2016): 4.00.

ISSN

2218-4333 (online)

Current Issue

Other Issues: Previous | Next | Latest | Archive | Issue 6 (9)

Contents Volume 12 Issue 6 June 24, 2021

Opinion Review

Health Council of the Netherlands and evaluation of the fifth generation, 5G, for wireless communication and cancer risks

Lennart Hardell

World J Clin Oncol 12(6):393-403. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.393

(0) | Open

Review

Breast cancer: Muscarinic receptors as new targets for tumor therapy

Alejandro Español, Agustina Salem, Yamila Sanchez, María Elena Sales

World J Clin Oncol 12(6):404-428. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.404

(0) | Open

Minireviews

Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase

Kashif Asghar, Asim Farooq, Bilal Zulfiqar, Asif Loya

World J Clin Oncol 12(6):429-436. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.429

(0) | Open

Imaging diagnosis of bronchogenic carcinoma (the forgotten disease) during times of COVID-19 pandemic: Current and future perspectives

Ravikanth Reddy

World J Clin Oncol 12(6):437-457. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.437

(0) | Open

Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention

Ester Oneda, Chiara Abeni, Laura Zanotti, Elisabetta Zaina, Sara Bighè, Alberto Zaniboni

World J Clin Oncol 12(6):458-467. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.458

(0) | Open

Clinical and Translational Research

Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancer

Jordan T Lee, Chad W Wagoner, Stephanie A Sullivan, Dean J Amatuli, Kirsten A Nyrop, Erik D Hanson, Lee Stoner, Brian C Jensen, Hyman B Muss, Claudio L Battaglini

World J Clin Oncol 12(6):468-481. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.468

(0) | Open

Meta-Analysis

Phytochemically rich dietary components and the risk of colorectal cancer: A systematic review and meta-analysis of observational studies

Pia Borgas, Guadalupe Gonzalez, Kirill Veselkov, Reza Mirnezami

World J Clin Oncol 12(6):482-499. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.482

(0) | Open

Case Report

Long-term complete response in metastatic poorly-differentiated neuroendocrine rectal carcinoma with a multimodal approach: A case report

Silvia Della Torre, Germana de Nucci, Pietro Maria Lombardi, Samuele Grandi, Gianpiero Manes, Roberto Bollina

World J Clin Oncol 12(6):500-506. Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.500

(0) | Open